Information  X 
Enter a valid email address

Synairgen PLC Ord 1P (SNG)

Date Time Source Announcement
13 Nov 2020 5:03 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Lancet Respiratory Medicine publishes Phase 2 data
10 Nov 2020 1:47 pm
RNS
Holding(s) in Company
04 Nov 2020 5:51 pm
RNS
Holding(s) in Company
03 Nov 2020 9:00 am
RNS
Holding(s) in Company
02 Nov 2020 12:20 pm
RNS
Result of General Meeting and Total Voting Rights
  7:00 am
RNS
Result of Open Offer
28 Oct 2020 11:20 am
RNS
Holding(s) in Company
27 Oct 2020 8:35 am
RNS
Holding(s) in Company
21 Oct 2020 9:45 am
RNS
Holding(s) in Company
  9:40 am
RNS
Holding(s) in Company
16 Oct 2020 3:10 pm
RNS
Exercise of Options and Total Voting Rights
15 Oct 2020 5:35 pm
RNS
Exercise of Options and Total Voting Rights
  1:51 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Results of Placing
14 Oct 2020 5:32 pm
RNS
Placing and Open Offer
12 Oct 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
06 Oct 2020 8:55 am
RNS
Holding(s) in Company
02 Oct 2020 7:00 am
RNS
Appointment of Joint Broker
01 Oct 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:00 am
RNS
Price Monitoring Extension
29 Sep 2020 7:00 am
RNS
Clinigen signs MAP agreement with Synairgen
  7:00 am
RNS
Synairgen and Clinigen sign Managed Access Program
  7:00 am
RNS
Interim results for six months ended 30 June 2020
09 Sep 2020 7:00 am
RNS
Synairgen IP Update
08 Sep 2020 7:00 am
RNS
Positive interim analysis of SNG001 in COPD
07 Sep 2020 3:53 pm
RNS
Holding(s) in Company
03 Sep 2020 5:58 pm
RNS
Holding(s) in Company
01 Sep 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
24 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
21 Aug 2020 5:28 pm
RNS
Holding(s) in Company
13 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:57 am
RNS
Holding(s) in Company
10 Aug 2020 9:50 am
RNS
Holding(s) in Company
07 Aug 2020 8:22 am
RNS
Holding(s) in Company
05 Aug 2020 5:51 pm
RNS
Holding(s) in Company
31 Jul 2020 8:37 am
RNS
Holding(s) in Company
29 Jul 2020 4:43 pm
RNS
Holding(s) in Company
28 Jul 2020 3:13 pm
RNS
Holding(s) in Company
  9:01 am
RNS
Holding(s) in Company
27 Jul 2020 9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
23 Jul 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
22 Jul 2020 2:05 pm
RNS
Holding(s) in Company
21 Jul 2020 4:15 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Clarification Regarding COVID-19 Trial
20 Jul 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:01 am
GNW
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
  7:00 am
RNS
Positive results from trial in COVID-19 patients
15 Jul 2020 8:00 am
RNS
Holding(s) in Company
03 Jul 2020 12:43 pm
RNS
Holding(s) in Company
  12:38 pm
RNS
Holding(s) in Company
29 Jun 2020 3:18 pm
RNS
Result of AGM
22 Jun 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
19 Jun 2020 7:00 am
RNS
Grant of Options
18 Jun 2020 7:00 am
RNS
National expansion of home-based COVID-19 trial
17 Jun 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
12 Jun 2020 2:01 pm
RNS
Price Monitoring Extension
10 Jun 2020 5:32 pm
RNS
Holdings in Company
  5:27 pm
RNS
Holdings in Company
  10:46 am
RNS
Holding(s) in Company
03 Jun 2020 4:21 pm
RNS
Annual Report and Notice of Annual General Meeting
28 May 2020 7:00 am
RNS
Recruitment of Patients in SG016 Trial Completed
26 May 2020 7:00 am
RNS
Initiation of SNG001 in home setting
  7:00 am
RNS
Preliminary results for the year ended 31 Dec 2019
11 May 2020 5:41 pm
RNS
Holding(s) in Company
06 May 2020 5:07 pm
RNS
Holding(s) in Company
05 May 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
30 Apr 2020 12:09 pm
RNS
Extension of clinical study in COVID-19 patients
28 Apr 2020 5:16 pm
RNS
Holding(s) in Company
24 Apr 2020 5:10 pm
RNS
Holding(s) in Company
16 Apr 2020 5:35 pm
RNS
Holding(s) in Company
15 Apr 2020 1:30 pm
RNS
Holding(s) in Company
14 Apr 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
Result of General Meeting
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:00 am
RNS
Price Monitoring Extension
08 Apr 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
01 Apr 2020 4:56 pm
RNS
Holding(s) in Company
31 Mar 2020 5:58 pm
RNS
Holding(s) in Company
  4:42 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Commencement of dosing in COVID-19 trial
30 Mar 2020 4:42 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
27 Mar 2020 3:21 pm
RNS
Holding(s) in Company
26 Mar 2020 9:00 am
RNS
Result of Fundraising
25 Mar 2020 1:45 pm
RNS
Proposed Fundraising
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  8:24 am
RNS
Holding(s) in Company
23 Mar 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
20 Mar 2020 4:48 pm
RNS
Second Price Monitoring Extn
  4:40 pm
RNS
Price Monitoring Extension
  2:00 pm
RNS
Price Monitoring Extension
19 Mar 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
18 Mar 2020 7:00 am
RNS
Synairgen to start trial of SNG001 in COVID-19
10 Mar 2020 4:36 pm
RNS
Price Monitoring Extension
17 Oct 2019 3:53 pm
RNS
Holdings in Company
16 Oct 2019 7:30 am
RNS
Holding(s) in Company
30 Sep 2019 7:00 am
RNS
Half-year Report
27 Sep 2019 7:00 am
RNS
Phase II Biomarker Data for SNG001 to be presented
24 Jul 2019 7:00 am
RNS
Phase II Clinical Trial Update
08 Jul 2019 5:48 pm
RNS
Holdings in Company
03 Jun 2019 11:52 am
RNS
Result of AGM
18 Apr 2019 9:20 am
RNS
Directorate Change, Annual Report & Notice of AGM
05 Apr 2019 12:55 pm
RNS
Grant of Options
14 Mar 2019 7:00 am
RNS
Positive DSMC Review of Phase II Study for SNG001
25 Feb 2019 7:00 am
RNS
Preliminary results for the year ended 31 Dec 2018
17 Jan 2019 8:31 am
RNS
Update on LOXL2 programme with Pharmaxis
22 Oct 2018 10:05 am
RNS
Holding(s) in Company
  7:00 am
RNS
Part 2 start of Phase II COPD trial
16 Oct 2018 3:01 pm
RNS
Holding(s) in Company
15 Oct 2018 8:49 am
RNS
Holding(s) in Company
12 Oct 2018 11:05 am
RNS
Result of General Meeting
  10:29 am
RNS
Result of General Meeting
25 Sep 2018 5:56 pm
RNS
Result of Fundraise
  1:01 pm
RNS
Proposed Fundraise to raise c.�2.9 million
  1:00 pm
RNS
Half-year Report
28 Jun 2018 7:00 am
RNS
Positive SNG001 Biomarker Data in COPD Patients
26 Jun 2018 1:05 pm
RNS
Holding(s) in Company
22 Jun 2018 11:42 am
RNS
Result of AGM
  7:00 am
RNS
Synairgen Safety Data with SNG001 in COPD Patients
17 May 2018 7:00 am
RNS
Posting of Annual Report and Notice of AGM
16 Apr 2018 4:29 pm
RNS
Holding(s) in Company
06 Apr 2018 12:14 pm
RNS
Grant of Options
03 Apr 2018 5:21 pm
RNS
Holding(s) in Company
15 Mar 2018 3:13 pm
RNS
Issue of Equity
  3:11 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Preliminary results for year ended 31 Dec 2017
07 Feb 2018 7:00 am
RNS
Synairgen starts dosing in Phase II COPD study
14 Dec 2017 7:00 am
RNS
Update on LOXL2 Programme&Pharmaxis Collaboration
08 Nov 2017 4:31 pm
RNS
Holding(s) in Company
27 Sep 2017 7:00 am
RNS
Data update and clinical plan for COPD
  7:00 am
RNS
Interim results for six months ended 30 June 2017
13 Sep 2017 12:44 pm
RNS
Holding(s) in Company
06 Sep 2017 7:00 am
RNS
LOXL2 Inhibitor Update.
28 Jun 2017 12:41 pm
RNS
Result of AGM
05 Jun 2017 7:00 am
RNS
Posting of Annual Report and Notice of AGM
17 May 2017 7:00 am
RNS
Preliminary Results
27 Apr 2017 7:00 am
RNS
AZD9412 Update
27 Mar 2017 7:00 am
RNS
Holding(s) in Company
13 Mar 2017 3:10 pm
RNS
Holding(s) in Company
10 Mar 2017 8:34 am
RNS
Additional Positive Data in Lung Fibrosis
17 Jan 2017 2:46 pm
RNS
Holding(s) in Company
13 Oct 2016 10:44 am
RNS
Holding(s) in Company
12 Oct 2016 7:00 am
RNS
AZD9412 Clinical Trial Update
22 Sep 2016 7:00 am
RNS
Interim results for six months ended 30 June 2016
08 Sep 2016 7:00 am
RNS
Notice of Interim Results
14 Jun 2016 12:00 pm
RNS
Result of AGM
17 May 2016 7:00 am
RNS
Posting of Annual Report and Notice of AGM
21 Apr 2016 2:14 pm
RNS
Holding(s) in Company
23 Mar 2016 7:00 am
RNS
Exercise of Options
22 Mar 2016 7:00 am
RNS
Preliminary results for the year ended 31 Dec 2015
  7:00 am
RNS
Positive LOXL2 results
03 Mar 2016 7:00 am
RNS
Notice of Preliminary Results
16 Nov 2015 4:11 pm
RNS
Adoption of FRS 101 - Reduced Disclosure Framework
13 Nov 2015 3:08 pm
RNS
Holding(s) in Company
  11:41 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
12 Nov 2015 7:00 am
RNS
Directors' Share Purchase
28 Oct 2015 7:00 am
RNS
Grant of options
16 Sep 2015 7:00 am
RNS
Interim Results
21 Aug 2015 7:00 am
RNS
Notice of Interim Results
05 Aug 2015 7:00 am
RNS
Synairgen announces research collaboration
22 Jul 2015 7:00 am
RNS
AstraZeneca commences Phase II Trial
22 Jun 2015 1:41 pm
RNS
Result of AGM
02 Jun 2015 9:37 am
RNS
Holding(s) in Company
15 May 2015 11:04 am
RNS
Notice of AGM
22 Apr 2015 5:03 pm
RNS
Posting of Annual Report and Accounts
05 Mar 2015 12:55 pm
RNS
Richard Griffiths increases stake to 6.1 percent
03 Mar 2015 7:00 am
RNS
Preliminary Results
12 Feb 2015 12:44 pm
RNS
Holding(s) in Company
11 Nov 2014 2:34 pm
RNS
Exercise of options
04 Nov 2014 7:00 am
RNS
Grant of Options
08 Oct 2014 7:00 am
RNS
Exercise of options
25 Sep 2014 7:00 am
RNS
Interim results for the six months ended 30 June
17 Sep 2014 7:00 am
RNS
Notice of Interim Results
22 Jul 2014 5:23 pm
RNS
Holding(s) in Company
  11:11 am
RNS
Holding(s) in Company
  11:08 am
RNS
Holding(s) in Company
21 Jul 2014 3:53 pm
RNS
Holding(s) in Company
16 Jul 2014 7:00 am
RNS
Holding(s) in Company
15 Jul 2014 3:13 pm
RNS
Holding(s) in Company
04 Jul 2014 2:44 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Placing
25 Jun 2014 7:00 am
RNS
Holding(s) in Company
12 Jun 2014 1:10 pm
RNS
Exercise of Options
  7:00 am
RNS
Licence deal with AstraZeneca
09 Jun 2014 1:00 pm
RNS
Result of AGM
16 May 2014 7:00 am
RNS
Notice of AGM
09 May 2014 2:57 pm
RNS
Notice of Report and Accounts
20 Mar 2014 7:00 am
RNS
Preliminary Results
11 Mar 2014 5:05 pm
RNS
Holding(s) in Company
06 Mar 2014 12:58 pm
RNS
Holding(s) in Company
05 Mar 2014 7:00 am
RNS
Licensing Update, Placing & Notice of results
14 Oct 2013 9:05 am
RNS
Exercise of Options
12 Aug 2013 7:00 am
RNS
Half Yearly Report
18 Jul 2013 7:00 am
RNS
Positive anti-inflammatory and anti-viral data
03 Jul 2013 3:05 pm
RNS
Holding(s) in Company
10 Jun 2013 1:45 pm
RNS
Result of AGM
21 May 2013 11:10 am
RNS
Holding(s) in Company
09 May 2013 12:45 pm
RNS
Notice of AGM
09 Apr 2013 4:26 pm
RNS
Posting of Annual Report
12 Mar 2013 7:00 am
RNS
Grant of Options
13 Feb 2013 7:00 am
RNS
Preliminary Results
05 Dec 2012 7:00 am
RNS
Trading Update
30 Oct 2012 1:44 pm
RNS
Director/PDMR Shareholding
25 Sep 2012 7:00 am
RNS
Exercise of Options
31 Aug 2012 7:00 am
RNS
Synairgen presents proof of concept study
10 Aug 2012 7:00 am
RNS
Half Yearly Report
18 Jul 2012 7:00 am
RNS
Placing
25 Jun 2012 1:30 pm
RNS
Result of AGM
22 May 2012 7:30 am
RNS
Professor Stephen Holgate given prestigious Award
01 May 2012 12:55 pm
RNS
Holding(s) in Company
19 Apr 2012 7:00 am
RNS
Positive Phase II asthma data
02 Mar 2012 7:00 am
RNS
Notice of Report and Accounts
01 Feb 2012 7:00 am
RNS
Preliminary results
30 Jan 2012 7:00 am
RNS
Notice of Results
12 Dec 2011 7:00 am
RNS
Director's dealing
08 Dec 2011 7:00 am
RNS
End of Recruitment in Phase II Asthma Trial
25 Nov 2011 7:00 am
RNS
Positive Viral Pneumonia Study Results
10 Nov 2011 12:40 pm
RNS
Result of AGM
18 Oct 2011 1:50 pm
RNS
Notice of AGM and posting of Annual Reports
22 Sep 2011 3:10 pm
RNS
Grant of options
13 Sep 2011 7:00 am
RNS
Preliminary Results
09 Sep 2011 7:00 am
RNS
Change of Adviser
18 Jul 2011 7:00 am
RNS
Japanese Patent to be Granted
28 Jun 2011 7:00 am
RNS
Phase II asthma study - Interim Review and update
15 Jun 2011 3:56 pm
RNS
Holding(s) in Company
13 Jun 2011 11:54 am
RNS
Result of General Meeting
27 May 2011 1:00 pm
RNS
Fundraising
04 May 2011 7:00 am
RNS
Antiviral activity against Bird Flu
02 Feb 2011 11:31 am
RNS
Holding(s) in Company
01 Feb 2011 7:00 am
RNS
Half Yearly Report
03 Nov 2010 1:35 pm
RNS
Result of AGM
19 Oct 2010 7:00 am
RNS
US Patent
08 Oct 2010 9:00 am
RNS
Notice of AGM and Posting of
09 Sep 2010 7:00 am
RNS
Grant of Options
29 Jul 2010 7:00 am
RNS
Final Results
27 Jul 2010 7:00 am
RNS
Notice of Results
29 Jun 2010 7:00 am
RNS
Grant of Options
28 Jun 2010 7:00 am
RNS
Directorate Change
17 May 2010 7:00 am
RNS
Positive Influenza Data
06 May 2010 7:00 am
RNS
IFN-beta Patent Granted in Eu
01 Apr 2010 7:00 am
RNS
Phase II Trials
24 Feb 2010 3:27 pm
RNS
Holding(s) in Company
08 Feb 2010 7:00 am
RNS
Half Yearly Report
15 Jan 2010 7:00 am
RNS
Holding(s) in Company
12 Nov 2009 7:00 am
RNS
Successful Outcome of Phase 1
11 Nov 2009 1:24 pm
RNS
Result of AGM
09 Nov 2009 7:00 am
RNS
activity of interferon beta a
26 Oct 2009 7:00 am
RNS
Notice of Investor Conference
14 Oct 2009 2:35 pm
RNS
Notice of Annual Report and A
08 Sep 2009 11:25 am
RNS
Grant of Options
04 Sep 2009 7:00 am
RNS
Directorate Changes
  7:00 am
RNS
US Patent Granted
  7:00 am
RNS
Final Results
02 Sep 2009 7:00 am
RNS
Notice of Results
17 Jul 2009 3:00 pm
RNS
Holding(s) in Company
30 Jun 2009 9:56 am
RNS
Total Voting Rights
25 Jun 2009 2:36 pm
RNS
Holding(s) in Company
23 Jun 2009 7:00 am
RNS
Holding(s) in Company
15 Jun 2009 11:06 am
RNS
Second Closing of the Fundrai
12 Jun 2009 11:22 am
RNS
Result of General Meeting
27 May 2009 7:00 am
RNS
Fundraising Announcement
01 Apr 2009 7:00 am
RNS
Preliminary biomarker data
31 Mar 2009 7:00 am
RNS
Change of Adviser
26 Mar 2009 7:00 am
RNS
Half Yearly Results
24 Mar 2009 11:14 am
RNS
Notice of Results
17 Mar 2009 7:00 am
RNS
Progress update: Clinical Tri
13 Nov 2008 12:15 pm
RNS
Result of AGM
07 Nov 2008 3:25 pm
RNS
Change of NOMAD
31 Oct 2008 9:00 am
RNS
Total Voting Rights
20 Oct 2008 7:00 am
RNS
Director/PDMR Shareholding an
10 Oct 2008 1:53 pm
RNS
Posting of 2008 Annual Report
08 Oct 2008 9:12 am
RNS
Change of Adviser Name
22 Sep 2008 7:00 am
RNS
Research Update
04 Aug 2008 10:00 am
RNS
Director/PDMR Shareholding
31 Jul 2008 7:00 am
RNS
Final Results
29 Jul 2008 7:00 am
RNS
Commencement of Clinical Tria
14 Jul 2008 11:48 am
RNS
Notice of Results
23 May 2008 7:00 am
RNS
Presentation of data at ATS
13 Mar 2008 7:01 am
RNS
Director Shareholding
12 Mar 2008 7:01 am
RNS
Interim Results
25 Feb 2008 7:01 am
RNS
Notice of Results
11 Feb 2008 7:01 am
RNS
Patent Granted
12 Dec 2007 7:01 am
RNS
Research Collaboration
15 Nov 2007 7:01 am
RNS
Result of AGM
12 Nov 2007 8:25 am
RNS
Contract with Alpha Biologics
31 Oct 2007 12:45 pm
RNS
Director/PDMR Shareholding
28 Sep 2007 7:04 am
RNS
Licence/ Supply by Rentschler
26 Sep 2007 7:01 am
RNS
Final Results
20 Aug 2007 7:00 am
RNS
Notice of Preliminary Results
17 Aug 2007 1:52 pm
RNS
AIM Rule 26
16 Aug 2007 2:54 pm
RNS
Change of Adviser
28 Jun 2007 2:30 pm
RNS
Director/PDMR Shareholding
12 Jun 2007 7:01 am
RNS
Research Update
20 Mar 2007 4:07 pm
RNS
Holding(s) in Company
19 Mar 2007 7:00 am
RNS
Interim Results
23 Feb 2007 3:16 pm
RNS
Holding(s) in Company
13 Feb 2007 4:40 pm
RNS
Notice of Results
12 Dec 2006 11:55 am
RNS
Total Voting Rights
30 Nov 2006 3:18 pm
RNS
Director/PDMR Shareholding
15 Nov 2006 3:41 pm
RNS
Result of AGM
  7:00 am
RNS
Licenses novel Peptide
08 Nov 2006 11:11 am
RNS
Holding(s) in Company
  10:21 am
RNS
Director/PDMR Shareholding
18 Sep 2006 7:00 am
RNS
Final Results
01 Sep 2006 7:00 am
RNS
Notice of Results
14 Aug 2006 7:04 am
RNS
Licensing Deal
  7:00 am
RNS
Licensing Agreement
24 May 2006 7:00 am
RNS
Research Update
11 Apr 2006 12:55 pm
RNS
Directorate Change
23 Feb 2006 7:00 am
RNS
Interim Results
16 Jan 2006 11:00 am
RNS
Notice of Results
16 Nov 2005 3:40 pm
RNS
Director/PDMR Shareholding
15 Nov 2005 12:15 pm
RNS
Result of AGM
  7:00 am
RNS
Interferon-Beta Enters Clinic
14 Nov 2005 7:00 am
RNS
Change of Adviser
27 Sep 2005 7:00 am
RNS
Final Results
06 Sep 2005 9:00 am
RNS
Notice of Results
13 Jul 2005 11:18 am
RNS
Holding(s) in Company
22 Mar 2005 7:35 am
RNS
Published Research
18 Mar 2005 11:43 am
RNS
Holding(s) in Company
09 Mar 2005 7:00 am
RNS
Interim Results
  7:00 am
RNS
Collaboration with Centocor
28 Feb 2005 12:00 pm
RNS
Notice of Results
04 Nov 2004 9:27 am
RNS
Holding(s) in Company
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t